Molecular Pharmacology

Research Frontiers in Leucine Rich Repeat Kinase 2 Mutations and Parkinson Disease

Development of LRRK2 kinase inhibitors targeting pathogenic mutations and investigation of substrate selectivity in neurodegeneration.

All Molecular Pharmacology PhD categories